Concepedia

J M Wood

JM

Statistics

Publications

35

Citations

4.3K

H-Index

26

Active since

1976

Affiliations

Novartis (Switzerland)(Current)

Novartis (United States)

National University of Singapore

National University Cancer Institute, Singapore

J M Wood is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and vascular endothelial growth factor.

Publications per year

1976–2011

35

Publications

35

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

J M Wood, Guido Bold, Elisabeth Buchdunger et al. · PubMed · 2000 · 847 citations

, , +16

VEGF is major stimulator in model of choroidal neovascularization.

Nohoon Kwak, N. Okamoto, J M Wood et al. · PubMed · 2000 · 447 citations

, , +16

Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin

Joseph Rahuel, Vittorio Rasetti, Jürgen Maibaum et al. · Chemistry & Biology · 2000 · 321 citations · Full text

, , +16

Effects of PTK787/ZK 222584, a specific inhibitor of vascular endothelial growth factor receptor tyrosine kinases, on primary tumor, metastasis, vessel density, and blood flow in a murine renal cell carcinoma model.

Joachim Drevs, Ilse Hofmann, Harald Hugenschmidt et al. · PubMed · 2000 · 309 citations

, , +17

PKC412--a protein kinase inhibitor with a broad therapeutic potential.

D Fabbro, Stephan Ruetz, Stephan Bodis et al. · PubMed · 2000 · 270 citations

, , +15

1–5 of 35